{
    "2018-08-21": [
        [
            {
                "time": "",
                "original_text": "[增持评级]医药生物行业周报：27.8倍的估值 或许是左侧布局的起点",
                "features": {
                    "keywords": [
                        "医药生物",
                        "估值",
                        "左侧布局",
                        "增持评级"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药生物"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}